Back
Orion Group Holdings 10K Form
Buy
64
ORN
Orion Group Holdings
Last Price:
$7.25
Seasonality Move:
13.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-26 | 10Q | ORN/Orion Group Holdings Quarterly |
2024-03-01 | 10K | ORN/Orion Group Holdings Annual |
2023-10-27 | 10Q | ORN/Orion Group Holdings Quarterly |
2023-07-28 | 10Q | ORN/Orion Group Holdings Quarterly |
2023-05-15 | 10Q | ORN/Orion Group Holdings Quarterly |
2023-03-16 | 10K | ORN/Orion Group Holdings Annual |
Receive ORN News And Ratings
See the #1 stock for the next 7 days that we like better than ORN
ORN Financial Statistics
Sales & Book Value
Annual Sales: | $796.4M |
---|---|
Cash Flow: | $-12.5M |
Price / Cash Flow: | 24.44 |
Annual Sales: | $3.81 |
Price / Book: | 1.9 |
Profitability
EPS (TTM): | 0.05000 |
---|---|
Net Income (TTM): | $3M |
Gross Margin: | $91.2M |
Return on Equity: | 2.24% |
Return on Assets: | 0.74% |
Orion Group Holdings Earnings Forecast
Key Orion Group Holdings Financial Ratios
-
The Gross Profit Margin over the past 20 years for ORN is 11.45%.
-
The Selling, General & Administrative Expenses for ORN have been equal to 10.36% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of ORN is -0.21% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 13 years.
Orion Group Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Construction & Engineering |
Sector: | Industrials |
Current Symbol: | ORN |
CUSIP: | 68628V |
Website: | oriongroupholdingsinc.com |
Debt
Debt-to-Equity Ratio: | 0.15 |
---|---|
Current Ratio: | 1.38 |
Quick Ratio: | 1.33 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 16.84 |
ORN Technical Analysis vs Fundamental Analysis
Buy
64
Orion Group Holdings (ORN)
is a Buy
Is Orion Group Holdings a Buy or a Sell?
-
Orion Group Holdings stock is rated a BuyThe current Orion Group Holdings [ORN] share price is $7.24. The Score for ORN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.